FDA Drug Application (017566) for BREVICON 21-DAY by ALLERGAN SALES LLC

Back to FDA Applications sponsored by ALLERGAN SALES LLC

Application Number017566
Product Number001
FormTABLET;ORAL-21
Dosage0.035MG;0.5MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameBREVICON 21-DAY
Active IngredientETHINYL ESTRADIOL; NORETHINDRONE

Active IngredientCount
List of drugs with Active Ingredient ETHINYL ESTRADIOL226
List of drugs with Active Ingredient NORETHINDRONE82


Back to FDA Applications sponsored by ALLERGAN SALES LLC